すべての画像(1)

資料

原産地証明書（COO）/試験成績書（COA）

EMU075311

MISSION^® esiRNA

Name: MISSION<SUP>®</SUP> esiRNA
Brand: SIGMA

targeting mouse Egfr

ログイン組織・契約価格を表示する

すべての画像(1)

About This Item

UNSPSCコード:

41105324

NACRES:

NA.51

おすすめの製品

Slide 1 of 10

1 of 10

Sigma-Aldrich

EHU076761

MISSION^® esiRNA

Sigma-Aldrich

EHU019931

MISSION^® esiRNA

Sigma-Aldrich

EHU078751

MISSION^® esiRNA

Sigma-Aldrich

S1452

MISSION^® siRNAトランスフェクション試薬

Z691461

ユニバーサルチューブラック

Millipore

DVPP04700

PVDFメンブレンフィルター、0.65 μm孔径

Sigma-Aldrich

PHB00274

Ethyl 2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate

Sigma-Aldrich

EHU086621

MISSION^® esiRNA

Sigma-Aldrich

EHU065921

MISSION^® esiRNA

Sigma-Aldrich

SIC001

MISSION^® siRNA Universal Negative Control #1

詳細

製品種目

MISSION^®

形状

lyophilized powder

esiRNA cDNA標的配列

GCCTGTGGGCCTGACTACTACGAAGTGGAAGAAGATGGCATCCGCAAGTGTAAAAAATGTGATGGGCCCTGTCGCAAAGTTTGTAATGGCATAGGCATTGGTGAATTTAAAGACACACTCTCCATAAATGCTACAAACATCAAACACTTCAAATACTGCACTGCCATCAGCGGGGACCTTCACATCCTGCCAGTGGCCTTTAAGGGGGATTCTTTCACGCGCACTCCTCCTCTAGACCCACGAGAACTAGAAATTCTAAAAACCGTAAAGGAAATAACAGGCTTTTTGCTGATTCAGGCTTGGCCTGATAACTGGACTGACCTCCATGCTTTCGAGAACCTAGAAATAATACGTGGCAGAACAAAGCAACATGGTCAGTTTTCTTTGGCGGTCGTTGGCCTGAACATCACATCACTGGGGCTGCGTTCCCTCAAGGAGATCAG

Ensembl |マウスアクセッション番号

ENSMUSG00000020122

NCBIアクセッション番号

NM_007912

輸送温度

ambient

保管温度

−20°C

遺伝子情報

mouse ... EGFR(13649) , Egfr(13649)

詳細

MISSION^® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法的情報

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

保管分類コード

10 - Combustible liquids

引火点(°F)

Not applicable

引火点(℃)

Not applicable

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA）を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.

Began Gopalan et al.

Biomaterials, 35(26), 7479-7487 (2014-06-11)

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed lethal cancers in the world. We previously showed two imidazolium salts (IBN-1 and IBN-9) with a moderate efficacy for HCC. Here we report a more potent imidazolium compound IBN-65 (1-benzyl-2-phenyl-3-(4-isopropyl)-benzyl-imidazolium

Combined inhibition of rho-associated protein kinase and EGFR suppresses the invasive phenotype in EGFR-dependent lung cancer cells.

Ijeoma Adaku Umelo et al.

Lung cancer (Amsterdam, Netherlands), 90(2), 167-174 (2015-09-08)

Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastatic disease frequently a prominent feature at the time of diagnosis. The role of NSCLC-derived EGFR mutations in cancer cell proliferation and survival has been widely reported, but little

Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer.

Yong Bian et al.

Biochemical and biophysical research communications, 463(4), 612-617 (2015-06-06)

Lipid metabolism is dysregulated in many human diseases including atherosclerosis, type 2 diabetes and cancers. Fatty acid synthase (FASN), a key lipogenic enzyme involved in de novo lipid biosynthesis, is significantly upregulated in multiple types of human cancers and associates

c-Src-dependent transactivation of EGFR mediates CORM-2-induced HO-1 expression in human tracheal smooth muscle cells.

Chuen-Mao Yang et al.

Journal of cellular physiology, 230(10), 2351-2361 (2015-04-30)

Carbon monoxide (CO), a reaction product of the cytoprotective heme oxygenase (HO)-1, displays an anti-inflammatory effect in various cellular injuries, but the precise mechanisms of HO-1 expression remain unknown. We used the transition metal carbonyl compound carbon monoxide-releasing molecule-2 (CORM-2)

The Moraxella catarrhalis-induced pro-inflammatory immune response is enhanced by the activation of the epidermal growth factor receptor in human pulmonary epithelial cells.

Philippe Dje N'Guessan et al.

Biochemical and biophysical research communications, 450(2), 1038-1044 (2014-07-01)

Chronic lower airway inflammation is considered to be a major cause of pathogenesis and disease progression in chronic obstructive pulmonary disease (COPD). Moraxella catarrhalis is a COPD-associated pathogen causing exacerbations and bacterial colonization in the lower airways of patients, which

資料

MISSION^® esiRNA